|
It was reported that the patient developed diffuse lamellar keratitis (dlk) following the last surgery day in (b)(6) 2026.The dlk grade was not provided.The patient was treated with oral steroids per the physician's standard dlk treatment protocol.Follow-up information indicated that the dlk resolved with treatment, the patient was doing well, and there was no loss of best corrected visual acuity (bcva).No patient identifiers or additional information were provided.
|
|
Section a2 a3, a4 and a5: unknown/ not provided.Section b3 date of event: event occurred june 2026.Section d6a: if implanted, give date: not applicable, as the device is not an implantable.Section d6b: if explanted, give date: not applicable, as the device is not an implantable.Section h3: the device was not returned for evaluation; therefore, a failure analysis of the complaint device cannot be completed.A review of records including device history record and complaint trending will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.All pertinent information available to johnson & johnson surgical vision, inc has been submitted.
|